Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Prostatic Neoplasms × Etoricoxib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Prednisone 110 Docetaxel 86 Leuprolide 79 enzalutamide 67 Abiraterone Acetate 67 bicalutamide 53 Goserelin 50 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 42 Radiotherapy 39 abiraterone 24 gallium 68 PSMA-11 23 Magnetic Resonance Spectroscopy 23 apalutamide 22 Gonadotropin-Releasing Hormone 22 luprolide acetate gel depot 21 sipuleucel-T 20 Androgen Antagonists 20 Triptorelin Pamoate 18 Radiosurgery 18 cabazitaxel 16 Flutamide 16 pembrolizumab 15 Radiotherapy, Intensity-Modulated 15 cabozantinib 14 Prednisolone 14 Dutasteride 14 Dexamethasone 14 radium Ra 223 dichloride 13 fluciclovine F-18 12 Radiation 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00427999 2016-11-21

INV342

Novartis

Phase 2 Completed

67 enrolled 6 charts

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡